Radiologists analyzed gadolinium retention research and identified limitations to our current understanding of gadolinium-based contrast agent (GBCA) retention risks in a recent JAMA viewpoint.

Improving women’s understanding of baseline mammograms and their importance is necessary, according to new research published in the Journal of the American College of Radiology.

Though major medical associations advise against prostate cancer screening in men over the age of 70, treatment in elderly populations costs Medicare more than $400 million a year, according to research published online Sept. 13 in JAMA Oncology. These costs include claims for CT, MRI and bone scans for diagnosis and follow-up imaging.

The International Agency for Research on Cancer (IARC), a part of the World Health Organization, has published updated estimates on the global burden of cancer.

A growing number of women are learning about their breast cancer diagnosis over the phone, according to a new study published in Supportive Care for Cancer. How can healthcare providers prepare for delivering such big news in such an impersonal way?

In February, the National Institutes of Health (NIH), RSNA and American College of Radiology (ACR) cosponsored a workshop about the safety of gadolinium-based contrast agents (GBCAs). Now, they've published a "roadmap" about what researchers know—and don't know—about GBCAs.

Texas-based Solis Mammography has announced the national availability of its SmartCurve breast imaging technology in more than 50 centers across the nation.

Though the primary cause for radiology malpractice cases is misdiagnosis, breakdown in communication between radiologists and ordering providers now accounts for a growing proportion of lawsuits, according to a new analysis published in Current Problems in Diagnostic Radiology.